Panel Examines Medical Research Conflicts

A National Institutes of Health panel considers new disclosure requirements and restrictions on outside income for biomedical researchers. Washington Monthly reports 60 percent of U.S. clinical studies are funded by drug and biotech firms — a fact studies suggest can influence the outcome of research. Hear NPR's Renee Montagne and Shannon Brownlee, author of the Washington Monthly article.